Clarus Securities Stock Recommendations and Price Targets

This is a list of recent ratings by Clarus Securities.

DateCompany NameActionCurrent
Price
Price
Target
RatingImpact on
Share Price
6/3/2024
AEP
Atlas Engineered Products
UpgradeC$1.00Strong-BuyN/A
5/10/2024
CVX
CEMATRIX
UpgradeC$1.00Strong-BuyN/A
3/18/2024
FAR
Foraco International
Reiterated RatingC$2.00BuyN/A
2/6/2024
HLS
HLS Therapeutics
Reiterated RatingC$3.00BuyN/A
7/24/2023
PKANF
Simply Better Brands
Boost Price TargetC$0.00C$1.00 ➝ C$1.25Speculative BuyLow
4/25/2023
DCMDF
DATA Communications Management
Boost Price TargetC$2.00C$3.00 ➝ C$5.00Low
4/25/2023
PKANF
Simply Better Brands
Initiated Coverage$0.00BuyLow
3/17/2023
LTHCF
Lithium Ionic
Initiated Coverage$1.00BuyLow
7/25/2022
HLS
HLS Therapeutics
Reiterated RatingC$3.00 C$26.50BuyN/A
5/25/2022
HLF
High Liner Foods
Reiterated RatingC$13.00 C$26.50BuyN/A
5/11/2022
DCM
DATA Communications Management
Reiterated RatingC$3.00 C$2.50BuyN/A
5/5/2022
DCM
DATA Communications Management
Reiterated RatingC$3.00 C$2.50BuyN/A
4/27/2022
HLTRF
HLS Therapeutics
Lower Price TargetC$2.00C$33.00 ➝ C$26.50High
4/27/2022
HLS
HLS Therapeutics
Reiterated RatingC$3.00 C$26.50BuyN/A
4/18/2022
TER
Teradyne
Reiterated Rating$106.00 $11.00BuyN/A
4/12/2022
TER
Teradyne
Reiterated RatingC$106.00 C$11.00BuyN/A
3/28/2022
DCM
DATA Communications Management
Reiterated RatingC$3.00 C$2.50BuyN/A
3/21/2022
TER
Teradyne
Lower Price Target$106.00 $14.00BuyN/A
3/21/2022
HLS
HLS Therapeutics
Reiterated RatingC$3.00 C$33.00BuyN/A
3/17/2022
TRSSF
TerrAscend
Reiterated Rating$1.00BuyMedium
3/8/2022
DCM
DATA Communications Management
Reiterated RatingC$3.00BuyN/A
1/4/2022
TER
Teradyne
Reiterated Rating$106.00 $16.25BuyN/A
11/23/2021
TER
Teradyne
Reiterated RatingC$106.00 C$16.25BuyN/A
11/8/2021
PIF
Polaris Renewable Energy
Reiterated RatingC$12.00BuyN/A
11/5/2021
HLS
HLS Therapeutics
Reiterated RatingC$3.00 C$32.00BuyN/A